119 related articles for article (PubMed ID: 8258712)
1. Role of adjuvants in the modulation of antibody isotype, specificity, and induction of protection by whole blood-stage Plasmodium yoelii vaccines.
ten Hagen TL; Sulzer AJ; Kidd MR; Lal AA; Hunter RL
J Immunol; 1993 Dec; 151(12):7077-85. PubMed ID: 8258712
[TBL] [Abstract][Full Text] [Related]
2. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants.
Hunter RL; Kidd MR; Olsen MR; Patterson PS; Lal AA
J Immunol; 1995 Feb; 154(4):1762-9. PubMed ID: 7836760
[TBL] [Abstract][Full Text] [Related]
3. Long-lasting protective immune response to the 19-kilodalton carboxy-terminal fragment of Plasmodium yoelii merozoite surface protein 1 in mice.
Jeamwattanalert P; Mahakunkijcharoen Y; Kittigul L; Mahannop P; Pichyangkul S; Hirunpetcharat C
Clin Vaccine Immunol; 2007 Apr; 14(4):342-7. PubMed ID: 17314232
[TBL] [Abstract][Full Text] [Related]
4. Copolymer adjuvants in malaria vaccine development.
Hunter RL; Lal AA
Am J Trop Med Hyg; 1994; 50(4 Suppl):52-8. PubMed ID: 8172332
[TBL] [Abstract][Full Text] [Related]
5. [Protective immune mechanisms induced by cellular vaccine made of the erythrocytic Plasmodium yoelii].
Yuan J; Xu B; Liu BF
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):47-51. PubMed ID: 15052774
[TBL] [Abstract][Full Text] [Related]
6. Escheriosome entrapped soluble blood stage antigens impart protective immunity against a multi-drug resistant isolate of Plasmodium yoelii nigeriensis in BALB/c mice.
Sharma SK; Farah D; Misra-Bhattacharya S; Bajpai P; Agarwal A; Mohammad O
Vaccine; 2006 Feb; 24(7):948-56. PubMed ID: 16168527
[TBL] [Abstract][Full Text] [Related]
7. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
Rotman HL; Daly TM; Clynes R; Long CA
J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
[TBL] [Abstract][Full Text] [Related]
8. Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.
Daly TM; Long CA
Infect Immun; 1996 Jul; 64(7):2602-8. PubMed ID: 8698485
[TBL] [Abstract][Full Text] [Related]
9. Vaxfectin enhances immunogenicity and protective efficacy of P. yoelii circumsporozoite DNA vaccines.
Sedegah M; Rogers WO; Belmonte A; Belmonte M; Banania G; Patterson N; Ferrari M; Kaslow DC; Carucci DJ; Richie TL; Doolan DL
Vaccine; 2006 Mar; 24(11):1921-7. PubMed ID: 16298024
[TBL] [Abstract][Full Text] [Related]
10. Plasmodium yoelii: the role of the individual epidermal growth factor-like domains of the merozoite surface protein-1 in protection from malaria.
Calvo PA; Daly TM; Long CA
Exp Parasitol; 1996 Jan; 82(1):54-64. PubMed ID: 8617331
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic potential of liposomized integral membrane protein of Plasmodium yoelii nigeriensis against blood stage infection in BALB/c mice.
Sharma SK; Gupta C; Dwivedi V; Misra-Bhattacharya S; Mohammad O
Vaccine; 2007 Mar; 25(11):2103-11. PubMed ID: 17241709
[TBL] [Abstract][Full Text] [Related]
12. Influence of adjuvants on murine immune responses against the C-terminal 19 kDa fragment of Plasmodium vivax merozoite surface protein-1 (MSP-1).
Yang C; Collins WE; Xiao L; Patterson PS; Reed RC; Hunter RL; Kaslow DC; Lal AA
Parasite Immunol; 1996 Nov; 18(11):547-58. PubMed ID: 9226693
[TBL] [Abstract][Full Text] [Related]
13. Plasmodium: immunization with carboxyl-terminal regions of MSP-1 protects against homologous but not heterologous blood-stage parasite challenge.
Rotman HL; Daly TM; Long CA
Exp Parasitol; 1999 Jan; 91(1):78-85. PubMed ID: 9920045
[TBL] [Abstract][Full Text] [Related]
14. Multiple antigen constructs (MACs): induction of sterile immunity against sporozoite stage of rodent malaria parasites, Plasmodium berghei and Plasmodium yoelii.
Reed RC; Louis-Wileman V; Cosmai EV; Fang S; Jue DL; Wohlhueter RM; Hunter RL; Lal AA
Vaccine; 1997 Apr; 15(5):482-8. PubMed ID: 9160515
[TBL] [Abstract][Full Text] [Related]
15. Oral immunization with a combination of Plasmodium yoelii merozoite surface proteins 1 and 4/5 enhances protection against lethal malaria challenge.
Wang L; Goschnick MW; Coppel RL
Infect Immun; 2004 Oct; 72(10):6172-5. PubMed ID: 15385527
[TBL] [Abstract][Full Text] [Related]
16. Parasite-specific immunoglobulin isotypes during lethal and non-lethal murine malaria infections.
Smith EC; Taylor-Robinson AW
Parasitol Res; 2003 Jan; 89(1):26-33. PubMed ID: 12474040
[TBL] [Abstract][Full Text] [Related]
17. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
Trimnell A; Takagi A; Gupta M; Richie TL; Kappe SH; Wang R
J Immunol; 2009 Nov; 183(9):5870-8. PubMed ID: 19812194
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen.
Freeman RR; Holder AA
Clin Exp Immunol; 1983 Dec; 54(3):609-16. PubMed ID: 6652973
[TBL] [Abstract][Full Text] [Related]
19. Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome.
Dwivedi V; Vasco A; Vedi S; Dangi A; Arif K; Bhattacharya SM; Owais M
Vaccine; 2009 Jan; 27(3):473-82. PubMed ID: 18996429
[TBL] [Abstract][Full Text] [Related]
20. Improved immunogenicity and efficacy of the recombinant 19-kilodalton merozoite surface protein 1 by the addition of oligodeoxynucleotide and aluminum hydroxide gel in a murine malaria vaccine model.
Near KA; Stowers AW; Jankovic D; Kaslow DC
Infect Immun; 2002 Feb; 70(2):692-701. PubMed ID: 11796601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]